{"id":1450,"createDateTime":"2026-11-20T00:59:16.152Z","archiveDateTime":"2027-11-30T00:00:00.000Z","name":"Managing GLP-1 RA side effects at the counter: Counselling, triage, referral","image":"e55f468e91c090a1b42c89f2111d84c74aced887950fd9fd9c268743","imageThumbnail":"acf6d6de4af8db0c43b23cc4b5efd43476ed8c4ce070590a7111a310","about":"Community pharmacists can identify and manage treatment-related side effects in patients receiving GLP-1 RA therapy. Learn to assess gastrointestinal symptoms, provide self-care advice, recognise red flags needing medical assessment and determine when to refer patients to their GP or emergency care.","type":"video","summaryViewCount":3,"startDateTime":null,"durationSecs":259,"endDateTime":null,"organisation":{"id":126,"name":"Novo","logoImage":"c96bed8528aaae2ae2d379c65c38f057d1c1b59251f98d2cd0b29ad1","logoImageThumbnail":"3a5c29ba7d9f777b4983bdf271ec88b03e1b995ea22b0f6c74e1da85","industry":"Pharmaceutical"},"provider":{"id":1,"name":"Praxhub","logoImage":"7d8c82e84cfeb7556fa842c1980c93b8144ab0959b0630c17e557baf","logoImageThumbnail":"78ba1e568155afb45aa67fc6f7337c076b0a1aa9182ceb80ac9b1095","industry":"Health Technology"},"commentCount":0,"likeCount":0,"targets":[{"id":5839,"association":null,"reward":null,"rewardImage":null,"rewardImageAspectRatio":null,"activityId":null}],"presenters":[{"id":84951,"specialty":{"id":188,"name":"Consultant Pharmacist"},"name":"Brooke Shelly","title":null,"profileImage":"5676243f0fbb26e1eca64f24fc6811c85235aeb28228565d8ba36726","profileImageThumbnail":"6f24bb891b0011044390f0592534bb04fb8b3d32d8139a67d58849a6"}],"relatedEducation":[{"id":1442,"name":"Oral or Injectable? Exploring the Future of Incretin-Based Obesity Care","image":"ce7ac9fd856d56f41c280f914d8a62dd3130d022c35223bcc589297c","imageThumbnail":"229e818ff45837bcdd010d299ec8f14d9b8d7445a9655a317effdc88","type":"zoom-webinar","startDateTime":"2026-12-02T08:30:00.000Z","durationSecs":5400,"associationEducationTypes":["EA","RP"],"organisation":{"id":126,"name":"Novo"}},{"id":1448,"name":"Counselling patients with obesity on oral semaglutide administration and medicine interactions","image":"04b98c95693a4d6595c71ba0b85d09e5fb3dbd21947ffb6e58240522","imageThumbnail":"f66b8e97b158d5816e2171adf39c2bc926b2414e75ff15f4cda3321a","type":"video","startDateTime":null,"durationSecs":206,"associationEducationTypes":[],"organisation":{"id":126,"name":"Novo"}},{"id":1449,"name":"Counselling on dose escalation and medication errors","image":"340813c63d280cf048270300db278ee0c9f92ae469086f215d9d2c76","imageThumbnail":"5dd3517b892c3d91271b481e0d602e74954d6e0da5e99c551ab6ed9f","type":"video","startDateTime":null,"durationSecs":275,"associationEducationTypes":[],"organisation":{"id":126,"name":"Novo"}},{"id":1444,"name":"Closing Practice Gaps: Improving T2D in General Practice","image":"f4a94cac168e327411186627cefdcfe4449dee70518fd795322a41cc","imageThumbnail":"318076efda9b8efbe7eac1f31dc055694cea9b5eb3ab554a1eb61a83","type":"video","startDateTime":null,"durationSecs":5400,"associationEducationTypes":["EA","MO","RP"],"organisation":{"id":126,"name":"Novo"}},{"id":1414,"name":"Closing Practice Gaps: Improving T2D in General Practice - Patient Identification Activity","image":"08aa34ff8974e243d4ff8d66e773b4f1edfe98ebd80d91a27e66380c","imageThumbnail":"80975b00b26a775ec3d6cfa8780089e43c51ec1940b219bd87c21349","type":"video","startDateTime":null,"durationSecs":167,"associationEducationTypes":["MO"],"organisation":{"id":126,"name":"Novo"}},{"id":1402,"name":"Above target: When does HbA1c require action?","image":"94cde287e85176375b48b2b2a9513c04eca617c59ba74ec2eec35687","imageThumbnail":"4e1554b7cbc5953361ac93d3c3e542740e5edbb314b849e6da6ab511","type":"video","startDateTime":null,"durationSecs":699,"associationEducationTypes":["RP"],"organisation":{"id":126,"name":"Novo"}}]}